Just a moment, the page is loading...

GSK-107625




Efficacy, safety, reactogenicity and immunogenicity study of the lyophilised formulation of Rotarix vaccine in healthy Japanese infants
Rotavirus Vaccine
107625
NCT00480324 2015-001543-36
Infections, Rotavirus
Phase 3
May 2013